Literature DB >> 18374872

Immunohistochemistry staining of C4d to diagnose antibody-mediated rejection in cardiac transplantation.

Savitri E Fedson1, Silver S Daniel, Aliya N Husain.   

Abstract

BACKGROUND: Antibody-mediated rejection (AMR) is associated with poorer outcomes in cardiac transplantation. The clinical diagnosis of AMR has been confirmed by immunofluorescence for C4d on fresh-frozen cardiac tissue. Immunohistochemistry (IHC) has been suggested as a more practical diagnostic tool because it can be performed on routine paraffin-embedded tissue. There are few published data about hemodynamics and C4d staining. We prospectively performed C4d staining on endomyocardial biopsies (EMBs) and present the pattern of tissue staining and its correlation with intracardiac hemodynamics.
METHODS: EMBs were evaluated by IHC for C4d staining and graded for cellular rejection using ISHLT criteria on hematoxylin-and-eosin-stained sections. Hemodynamic measurements were taken concurrently. Staining for C4d was described as absent, present with serum staining, or present with only tissue staining. The pattern of tissue staining was categorized by location of staining and correlated with intracardiac hemodynamics. Patient demographics, cytomegalovirus status, panel-reactive antibody levels and hemodynamics were analyzed by analysis of variance and chi-square statistics.
RESULTS: Of the 400 EMBs, 50 had no C4d staining, 330 had tissue and serum staining, whereas 20 had only tissue staining. Forty EMBs had endothelial staining, including 35 with serum and 5 with isolated tissue staining. Endothelial staining correlated with higher intracardiac pressures.
CONCLUSIONS: IHC staining for C4d has been suggested for the diagnosis of AMR. Our data suggest there is a high rate of background C4d staining, but endothelial staining correlates with poorer hemodynamics. Methods for IHC staining and interpretation need to be standardized for widespread use and clinical studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18374872     DOI: 10.1016/j.healun.2008.01.003

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  7 in total

Review 1.  Pros and cons for C4d as a biomarker.

Authors:  Danielle Cohen; Robert B Colvin; Mohamed R Daha; Cinthia B Drachenberg; Mark Haas; Volker Nickeleit; Jane E Salmon; Banu Sis; Ming-Hui Zhao; Jan A Bruijn; Ingeborg M Bajema
Journal:  Kidney Int       Date:  2012-02-01       Impact factor: 10.612

Review 2.  Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications.

Authors:  Nayan J Sarma; Venkataswarup Tiriveedhi; Nataraju Angaswamy; T Mohanakumar
Journal:  Hum Immunol       Date:  2012-07-10       Impact factor: 2.850

3.  Report from a consensus conference on antibody-mediated rejection in heart transplantation.

Authors:  Jon Kobashigawa; Maria G Crespo-Leiro; Stephan M Ensminger; Hermann Reichenspurner; Annalisa Angelini; Gerald Berry; Margaret Burke; Lawrence Czer; Nicola Hiemann; Abdallah G Kfoury; Donna Mancini; Paul Mohacsi; Jignesh Patel; Naveen Pereira; Jeffrey L Platt; Elaine F Reed; Nancy Reinsmoen; E Rene Rodriguez; Marlene L Rose; Stuart D Russell; Randy Starling; Nicole Suciu-Foca; Jose Tallaj; David O Taylor; Adrian Van Bakel; Lori West; Adriana Zeevi; Andreas Zuckermann
Journal:  J Heart Lung Transplant       Date:  2011-03       Impact factor: 10.247

4.  Role of alloimmunity and autoimmunity in allograft rejection.

Authors:  Babak Banan; Zhongping Xu; Muthukumar Gunasekaran; T Mohanakumar
Journal:  Clin Transpl       Date:  2013

5.  Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Methods Mol Biol       Date:  2013

6.  Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes.

Authors:  Grace W Wu; Jon A Kobashigawa; Michael C Fishbein; Jignesh K Patel; Michelle M Kittleson; Elaine F Reed; Krista K Kiyosaki; Abbas Ardehali
Journal:  J Heart Lung Transplant       Date:  2009-03-14       Impact factor: 10.247

Review 7.  Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection.

Authors:  Carrie L Butler; Nicole M Valenzuela; Kimberly A Thomas; Elaine F Reed
Journal:  J Immunol Res       Date:  2017-03-08       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.